Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Weak headline result, but underlying trends are ok

MA Financial Group
3:27pm
February 22, 2024
MAF’s FY23 NPAT (~A$42m) was -32% on the pcp and ~-12% below consensus (A$47m). Headline result figures disappointed due mainly to higher costs than consensus. Broadly, the build of MA’s underlying business appears to be going ok. However, a difficult cyclical environment and the higher FY23 investment spend repeating in FY24, means upside here is more an FY25 story, in our view. We lower our MAF FY24F/FY25F EPS by -17%/-21% mainly on higher cost assumptions. Our PT is set at A$6.07 (previously A$6.25) on lower earnings estimates offset by a valuation roll-forward. We still see solid medium term value, and maintain our ADD call.

Aerospace & Defence gaining traction

PWR Holdings Limited
3:27pm
February 22, 2024
PWH’s 1H24 result was comfortably above our expectations with growth in Emerging Technologies the key highlight. Divisional revenue growth: Motorsports (ex-Emerging Tech) +5%, Aftermarket +7%, Emerging Technologies +88%, OEM +12%. Key positives: Aerospace & Defence revenue jumped 124% with a stronger pipeline compared to six months ago; EBITDA margin increased 110bp to 28.6% mainly due to an improved sales mix and increased operating efficiency; Balance sheet remains healthy with net cash (ex-leases) of $15.6m. Key negative: ROE fell 100bp to 26.7%. We make minor adjustments to FY24-26 earnings forecasts with EBITDA increasing by between 1-2% and underlying NPAT also rising by 1-2% Our target price increases to $14.25 (from $11.90) reflecting changes to earnings forecasts and a roll-forward of our model to FY25 forecasts. Add rating maintained. While the stock is not cheap (38.4x FY25F PE), we believe PWH is a high-quality business with a strong track record of growth. With a healthy pipeline of opportunities across all key segments (particularly Aerospace & Defence), we expect this growth trend to continue over the long term.

1H24 earnings: Earnings shrunk

The Reject Shop
3:27pm
February 22, 2024
First the good news. TRS outperformed most companies in our coverage universe with +2.3% LFL sales growth in 1H24 (although this was a little less than we had expected). The offering of well-priced every day essentials seems to have resonated with its customers, seeing both transaction and units growth over the period. This has resulted in a shift in sales mix away from general merchandising to the lower margin consumables. Sales momentum continued into the first 7 weeks of 2H24. Then the bad news. There was substantial shrinkage (shoplifting) over the course of the half, impacting EBIT by $4m, which was down 16% yoy. Without this impact, EBIT would have been flat. We maintain our ADD rating on TRS but reduce our target price to $5.40 (was $6.25) due to reduced earnings estimates in the current year.

Delivering on promised returns

Mitchell Services
3:27pm
February 22, 2024
The 1H result was in-line with quarterly reporting, with few surprises. The 2cps interim div reflects a 100% NPAT payout in excess of policy and complimenting accretion from the on-market buyback. The current ex-growth phase looks set to continue, supporting compelling forecast free cash flow yield (22-30%) and dividend yield (9-11%). At only (2.0x FY24F EV/EBITDA MSV still looks disregarded by the market. MSV trades at a sharp discount to direct peers and recent drilling M&A.

Still trying to adjust to the post-COVID world

Healius
3:27pm
February 22, 2024
FY24 underlying profit has been downgraded by double digits, given lower 2H expectations for Pathology volumes and benefits. While 1Q saw high single -digit Pathology volumes and double-digit benefit growth, momentum faded in 2Q, with both metrics tracking in the low single-digit range. It appears soft GP attendances, coupled with labour shortages and inflationary pressures, continue to conspire in holding back volumes. While management is aiming to accelerate Pathology restructuring to better match volumes with costs, activity to date seems to have done little to move the dial, putting greater uncertainty around a solution and complete near-term turnaround. We lower our FY24-26 estimates, with our target price decreasing to A$1.37. Hold.

Less than compelling

Clinuvel Pharmaceuticals
3:27pm
February 22, 2024
CUV’s posted a weaker than expected 1H24 result, with negligible top-line growth combined with a significant increase in the cost base (clinical activity, staff retention incentives and an increase in service roles) to meet future demand. While the top-line growth was disappointing, paired with large cost base increases and Board turnover it failed to inspire much confidence. Investors remain in the dark on US vs EU performance outside of cursory commentary. There was no discussion around capital management plans outside of stockpiling cash, now ~25% of the market cap. We downgrade our target price to A$16 p/s (from A$22 p/s) and recommendation moves to Hold, noting increased risk around board and disclosure. Traders may find an opportunity down here, but equally prepared to wait until a number of investor concerns are addressed.

Wasn’t RIO supposed to buy everyone?

Rio Tinto
3:27pm
February 21, 2024
An in-line CY23 result, although RIO hasn’t been immune to weakening metal prices (ex-iron ore) and global inflation pressures. Looks can be deceiving, but RIO commentary continues to run contrary to a popular view that the big miner might be an aggressive acquirer pursuing M&A. Despite the challenges, and capex in OTUG, RIO still generated FCF of US$7.7bn in CY23. We maintain a Hold rating on RIO, with a A$127ps Target Price.

Stage one done

IRESS
3:27pm
February 21, 2024
IRE reported FY23 in-line with guidance: revenue of A$625.7m (+1.6%); and underlying EBITDA of A$128.3m (top-end of previous guidance). Whilst FY24 and exit run-rate ‘underlying’ EBITDA guidance was upgraded, IRE somewhat shifted the goal posts. ‘Adjusted’ EBITDA expectations now include ongoing project related costs of ~A$20m previously expected to be non-recurring. Positives included all divisions, excluding Super, showing hoh EBITDA growth; and confidence in two divestments. We expect significant de-leverage in 2H24. We can see an ongoing path for improvement for IRE and a material divestment (Mortgages) is a relatively near-term catalyst. However, after a solid re-rate and lower clarity on ‘base’ free cash flow generation post this result, we move to Hold.

A transitional period with some seasonal elements

Camplify Holdings
3:27pm
February 21, 2024
Camplify’s (CHL) 1H24 result beat our GTV/revenue forecasts (+4-8%) showing robust pcp growth (+~95%). Excl. ~A$0.9m of one-off MyWay setup and platform integration costs, normalised EBITDA was -A$1.4m (vs -A$1.8m in the pcp). The stock closed down ~17% on result day, which we largely attribute to some seasonality in CHL’s key headline metrics (future bookings, gross margins, etc). We make several cost and margin assumption changes over the forecast period (details below). Our price target remains unchanged at A$2.85 and we maintain an Add recommendation on the stock.

Rebasing expectations

Corporate Travel Management
3:27pm
February 21, 2024
1H24 was broadly in line with our forecast but was below consensus estimates. Due to 2Q macro issues and the UK Bridging contract materially underperforming expectations, CTD has revised its FY24 EBITDA guidance by 15.4% at the mid-point. Off this new base, CTD has a five-year strategy to double profits by FY29. The quantum of the earnings downgrade is clearly disappointing. Given the aggressive pivot in earnings guidance from the AGM last year, the market may take time to rebuild its confidence in the outlook. However, if CTD delivers even close to its five-year strategy, the share price will be materially higher in time. We maintain an Add rating with a new price target of A$20.65.

News & Insights

From Houthi attacks on Suez Canal shipping to Trump’s Operation Rough Rider and Iran’s nuclear facility strikes, explore how these events shape oil prices.

At the beginning of the week, I was asked to write something about Iran. When I started looking at what had been happening , I realised that what we were talking about begins with an action by a proxy of Iran back in November 2023. How  that was initially handled with the Biden regime, and how then it was dealt with  deftly by Trump this year,   in turn led to  the need for an attack on Iran's nuclear facility.

Winston Churchill noted in his first volume of his history of the Second World War that it was important to understand that the United States is primarily a naval power. Indeed, the US remains the world dominant naval power. As such, two major strategic concerns remain for the US : the control of the Suez Canal and the Panama Canal .

To the US The idea that another country might block access to either of these must be intolerable. Yet what began happening, beginning on the 19th November 2023, was that , Houthi rebels that controlled a the northern part of a small country in southwestern Arabia, began to act. These Houthi rebels were acting as a proxy for Iran. They were funded by Iran, and armed with Ship-killing rockets, by Iran.

By February 2024, they had attacked 40 ships which had been attempting to sail northwards towards the Suez Canal. By March 2024, 200 ships had been diverted away from the Suez Canal and forced to make the longer and more expensive voyage around the Cape of Good Hope of South Africa. At this point, I think The Economist magazine said that this was the most severe Suez crisis since the 1950s.

The U.S. did respond. On the 18th December 2023, the U.S. had announced an international maritime force to break the Houthi blockade. On the 10th January, the UN National Security Council adopted a resolution demanding a cessation of Houthi attacks on merchant vessels.

As of the 2nd January 2024, the Houthis had already recorded 931 American and British airstrikes against sites in Yemen. Then Trump came to power. To Trump, the idea of the proxy of Iran blockading the Suez Canal could not be tolerated.

From the 15th March 2025, Trump began "Operatation  Rough Rider". This was named for the cavalry commanded by the then-future President Theodore Roosevelt, who charged up San Juan Hill in Cuba during the Spanish-American War of 1898. The U.S. then hit the Houthis with over a thousand airstrikes. So they were bombing at ten times the rate they previously had been. The result of that was that by the 6th March 2025, Trump announced that the Houthis, these proxies of Iran, had capitulated as part of a ceasefire brokered by Oman. This directly led to the main game.

It was obvious that the decision to do the unthinkable, and block the Suez Canal, had come from Iran.
What other unthinkable things was Iran considering?

It is obvious that Trump now believed that the next unthinkable thing that Iran was considering was nuclear weapons. As Iran's other proxies collapsed, Iran's air defence collapsed. In turn, this gave Trump the room to act, and he took it. He launched a bombing raid which severely disabled Iran's nuclear capacity. Some say it completely destroyed it.

Iran retaliated by launching 14 rockets at the American base in Qatar, warning the Americans this was going to happen, and this had no other effect than allowing Iran to announce a glorious victory by themselves over the Americans. Iran had thought the unthinkable and had achieved what was, to them, as a result, an unthinkable reverse.

The ceasefire that has followed has been interpreted by markets as a relief from major risk. Now, the major effect of this on markets has been a dramatic rocketing in the oil price, followed by a fall in the oil price. So I thought I’d look at the fundamentals of the oil price, from running two of my models of the Brent price, using current fundamentals.

Now, the simplest model that I’ve got explains 63% of monthly variation of the Brent oil price. And it’s based on two things. One is the level of stocks in the U.S., which are published every week by the Energy Information Administration .  Those stocks are  down a bit in the most recent months because this is the summer driving season where oil stocks are being drawn down to provide higher demand for gasoline. So that’s a positive thing. And the other thing that I’ve been talking about this year is that I think  we’re going to see a steady fall in the U.S. dollar, and that’s going to generate the beginning of a recovery in commodities prices. So if I also put the U.S. dollar index into this model, it gives me an equilibrium model now of $78.96. And that’s about $US12  higher than the oil price was this morning.

If I strengthen that model by adding the U.S. CPI, because, you know, the cost of production cost of oil raises over time, that increases the power of the model . And that lifts the equilibrium price very considerably to $97 a barrel, which is $30 a barrel higher than it currently is. So I regard that as my medium-term model, and the first one is my short-term model.

What’s really interesting is that the U.S. dollar  has continued to fall.  That puts further upward pressure  on the oil price. So in spite of this crisis having been solved, I think we’re going to see more upward price action on the oil price by the end of the year.

Read more
The US economy is growing strongly at 2.34% in Q2 2025 but is expected to slow to 1.4% in 2025, with falling interest rates and a weaker US dollar likely to boost commodity prices, benefiting Australian markets. Michael Knox discusses.

We think the US economy is currently experiencing solid growth, with data from the Chicago Fed  National Activity Index indicating an annual growth rate of just above  2%. This aligns with projections from other parts of the Federal Reserve System, such as the New York Fed. The New York Fed’s weekly Nowcast, updated every Friday, estimates that for the second quarter of 2025, the US economy is growing at an annualised rate of 2.34%, surpassing the 2% mark. This robust growth is consistent with our model’s view that the US economy is now performing strongly. However, we anticipate a slowdown in the second half of 2025.

On 18 June the Fed released its Summary of Economic Projections  with the Federal Reserve’s  forecasting US GDP growth to drop to 1.4% in 2025, down from their March estimate of 1.7%. Looking further ahead, growth is expected to pick up slightly to 1.6% in 2026 and 1.8% in 2027, aligning with the long-term trend growth rate of around 1.8%. We believe this recovery trend could be even  higher,  driven by reduced regulation under the second Trump administration and aggressive tax write-offs for companies building factories in the US, allowing 100% write-offs for equipment and buildings in the first year. This policy should foster stronger systemic growth.

Economic Projections of the Federal Reserve

The Fed expects that as the economy slows,  unemployment is projected to rise to 4.5% from the current level of 4.2%. Inflation, measured by the Consumer Price Index (CPI), is running at 3.5% this year, approximately 50 basis points higher than the Personal Consumption Expenditures (PCE) index of 3.0%, with 1.6% of this  inflation  attributed to tariffs. The Fed expects PCE Inflation  to ease to 2.4% in 2026 and 2.1% in 2027. The Federal Reserve anticipates cutting the effective  federal funds rate, currently at 433 basis points (according to the New York Fed), by 50 basis points by the end of 2025, followed by an additional 25 basis points in each of the next two years. This aligns with our own Fed Funds rate  model’s current equilibrium federal funds rate of  3.85% . The Fed Outlook  supports our scenario of a slowing US economy and rate cuts in the second half of 2025 and beyond. A falling US dollar is then expected to exert upward pressure on commodity prices, benefiting Australian Equity markets.

Taking questions during the Press Conference after releasing the Fed statement  ,Federal Reserve Chair Jay Powell,   addressed the certainty and uncertainty surrounding the inflationary effects of tariffs. Initially, at the start of 2025, the inflationary impact of tariff policies was unclear, but three months of favourable inflation data have provided this clarity, indicating that the inflationary effects are less severe than anticipated. Powell noted that the Feds own uncertainty on the inflationary effects of  tariffs  peaked in April 2025, and the Federal Reserve now has a clearer understanding that  the inflation effects, are lower than initially expected.

The Fed view  supports our own scenario of a slowing US economy in the second half of 2025, allowing for Fed rate cuts  . This in turn should then lead to  a falling US dollar, which we in turn  expect to drive rising commodity prices.

Read more
The Your Wealth publication is our half yearly scrutiny into current affairs for wealth management. Our latest Issue 29 is out now.

The second half of 2025 will be an interesting time for everyone. Geopolitical uncertainty prevails. How will all of this impact the Australian investor and in particular, their wealth and retirement savings? Whether you are an accumulator, saving for short- and long-term goals, or a retiree, hoping for a comfortable retirement, the ability to manage this uncertainty will be key.

When we published the previous Your Wealth – First Half 2025, the Division 296 Bill (Div296) was also facing uncertainty. The Bill was eventually blocked in the Senate prior to the Federal Election. The Labor Party succeeded in winning so it’s Ground Hog Day for Div296. The Government doesn’t have the numbers in the Senate to pass the Bill without support from other parties. The Greens are the likely negotiating party but will undoubtably have their own agenda. Regardless, there is a high probability this legislation will be passed once Parliament resumes.

Our message to our clients is to wait until we know more details and to not act in haste.

In addition to our Feature Article which provides further insights on Div296, this edition also Spotlights the Aged Care changes due this year, with the start date pushed back to 1 November.

We hope readers enjoy this edition of Your Wealth.


Morgans clients receive exclusive insights such as access to our latest Your Wealth publication. Contact us today to begin your journey with Morgans.

      
Contact us
      
Read more